OnCore Login

Return to Trial Database

BTCRC-LUN18-363

A Phase II Study of Chemo-Immunotherapy Followed by Durvalumab (MEDI4736) and Ceralasertib (AZD6738) in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Big Ten Cancer Research Consortium BTCRC-LUN18-363

Status

Enrollment Closed

Cancer Type(s)

Lung

Study Contact

(317) 921-2050
studies@hoosiercancer.org

Trial Locations

All sites in which the trial BTCRC-LUN18-363 being conducted in.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
The Ohio State University
University of Illinois Cancer Center
University of Iowa Holden Comprehensive Cancer Center
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278